The authorization raised immediate questions about who would get access to the antibody treatments, which are in short supply.
Published: November 10, 2020 at 03:03AM
from NYT Health https://ift.tt/3pgF88r
The authorization raised immediate questions about who would get access to the antibody treatments, which are in short supply.
Published: November 10, 2020 at 03:03AM
from NYT Health https://ift.tt/3pgF88r